Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032

Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6649
Buy Now

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Congestive Heart Failure Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    ACE Inhibitors
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Angiotensin 2 Receptor Blockers
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Beta Blockers
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Diuretics
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Aldosterone Antagonists
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Inotropes
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Others
        6.7.1 Market Trends
        6.7.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intravenous
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel 
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    Drivers, Restraints, and Opportunities
    10.1    Overview
    10.2    Drivers
    10.3    Restraints
    10.4    Opportunities
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AstraZeneca plc
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Bayer AG
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Novartis AG
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

Figure 1: Global: Congestive Heart Failure Drugs Market: Major Drivers and Challenges
Figure 2: Global: Congestive Heart Failure Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Congestive Heart Failure Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Congestive Heart Failure Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Congestive Heart Failure Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Congestive Heart Failure Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Congestive Heart Failure Drugs (Beta Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Congestive Heart Failure Drugs (Beta Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Congestive Heart Failure Drugs (Diuretics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Congestive Heart Failure Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Congestive Heart Failure Drugs (Inotropes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Congestive Heart Failure Drugs (Inotropes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Congestive Heart Failure Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Congestive Heart Failure Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Congestive Heart Failure Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Congestive Heart Failure Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Congestive Heart Failure Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Congestive Heart Failure Drugs Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Congestive Heart Failure Drugs Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Congestive Heart Failure Drugs Industry: Value Chain Analysis
Figure 83: Global: Congestive Heart Failure Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Congestive Heart Failure Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Congestive Heart Failure Drugs Market: Competitive Structure
Table 7: Global: Congestive Heart Failure Drugs Market: Key Players

Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More